Safety & Efficacy of Unrelated Umbilical Cord Blood Microtransplantation

Updated 05/14/2024

Status Recruiting

Clinical Trial Summary

This study aimed to evaluate the safety and efficacy of unrelated umbilical cord blood microtransplantation in the treatment of AML patients by observing the factors related to the efficacy and adverse reactions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06105658
Study type	Interventional
Source	Anhui Provincial Hospital
Contact	Xiaoyu Zhu, MD
Phone	15255456091
Email	xiaoyuz@ustc.edu.cn
Status	Recruiting
Phase	Phase 2
Start date	October 2023
Completion date	February 1, 2026

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02244658` - Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia	Phase 3
	Completed	`NCT01462578` - Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)	Phase 2
	Completed	`NCT01188798` - Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies	Phase 3
	Completed	`NCT00854646` - Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)	Phase 1
	Completed	`NCT00152139` - Stem Cell Transplantation for Patients With Hematologic Malignancies	Phase 3
	Completed	`NCT00061581` - Experimental Bone Marrow Transplant Protocol	Phase 2
	Completed	`NCT01167166` - Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)	Phase 1/Phase 2
	Completed	`NCT01474681` - Safety and Tolerability of HSC835 in Patients With Hematological Malignancies	Phase 1/Phase 2
	Terminated	`NCT02255162` - Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML	Phase 1
	Active, not recruiting	`NCT01809392` - Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome	Phase 2/Phase 3
	Recruiting	`NCT00155844` - Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"	N/A
	Recruiting	`NCT03796390` - Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia	Phase 1
	Terminated	`NCT01621477` - T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant	Phase 2
	Completed	`NCT00559091` - A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia	Phase 2
	Completed	`NCT00015587` - Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)	N/A